news

2024 ciftis|ai empowerment accelerates the digital transformation of healthcare

2024-09-16

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

the ai ​​wave is sweeping the medical market. more and more medical companies are actively embracing ai, and the improvement of disease diagnosis and treatment efficiency and quality by medical artificial intelligence is obvious to all. at the 2024 china international fair for trade in services (hereinafter referred to as "ftis") health and hygiene services special exhibition, mindray medical exhibited a number of digital diagnosis and treatment products, covering digital imaging, digital monitoring, and digital testing. at present, mindray medical has initially completed the construction of an intelligent medical ecosystem of "equipment + it + ai", truly using technological means to solve the pain point of uneven distribution of high-quality medical resources. ai medical care, which reshapes the efficiency of medical services, will inject new impetus into the future development of the medical industry, and its importance in the field of trade in services will become increasingly prominent.

building a smart medical ecosystem

"digital transformation will provide china's medical industry with an opportunity to bridge the gap and overtake others. chinese medical device companies have also accumulated enough potential and will stand proudly at the forefront of this transformation," said li xiting, chairman of mindray medical, in a letter to shareholders in the 2023 annual report. digital transformation is also the direction that mindray medical has been working towards at this stage. at this year's trade in services fair, digitalization became the keyword for mindray medical's exhibition.

in the exhibition area, mindray medical showcased the company's many achievements in its digital transformation through digital imaging, digital monitoring, digital testing, and digital hospitals.

a relevant person in charge of mindray medical introduced to the beijing business daily reporter at the exhibition site that the company's ultra-high-end ultrasound platform resona a20 exhibited this time is the industry's first commercial device that can achieve super-resolution blood flow imaging in a clinical environment; the sv900 critical care ventilator is equipped with intelligent human-machine synchronization technology, which can intelligently identify the patient's spontaneous breathing status based on the multi-dimensional respiratory waveform morphology characteristics, automatically ventilate in accordance with the patient's respiratory rhythm, and improve the patient's human-machine synchronization.

it is understood that through the combination with artificial intelligence, mindray medical has initially completed the construction of the "equipment + it + ai" intelligent medical ecosystem. through the integration and innovation of the "three rui" ecology and equipment, combined with big data and artificial intelligence, it provides medical institutions with digital overall solutions, truly using technology to solve clinical pain points.

the company's digital and intelligent overall solution has actually entered the hospital. for example, in renji hospital affiliated to shanghai jiaotong university school of medicine, mindray medical has created an industry-leading digital and intelligent overall solution from operating rooms, critical care, general care to smart hospital command centers. among them, the command center not only deploys the digitalization of operating rooms and the intelligent iot platform for life support equipment, but also integrates platforms such as internet hospitals and hospital operation data. in addition to meeting traditional needs such as remote surgical guidance, monitoring of vital signs of acute, anesthesia, and general care patients, the command center can also provide virtual scene experiences in virtual conference rooms, operating rooms, and intensive care units, providing strong technical support for promoting the high-quality development of hospitals.

continuous exploration of medical care + ai

the quality and efficiency of clinical diagnosis and treatment, doctor-patient satisfaction, and the benefits of hospital operations are rigid demands of the medical industry. with this as an anchor point, mindray medical began to explore large models in the critical care vertical field.

the department of critical care medicine is commonly known as the icu. there are a variety of medical equipment next to each bed in the icu, and the pain points of large amounts of clinical data, multiple dimensions, and difficulty in interpretation are more prominent. doctors face a large amount of multi-dimensional, continuously changing data, and they also need deep professional knowledge and rich clinical experience to accurately diagnose and use medications. in addition, icu patients are in critical condition, with complex diseases and rapidly changing conditions. medical staff need to spend a lot of time and energy every day to organize medical records and nursing records. these records are also the focus and difficulty of clinical quality control.

the industry's first ai-integrated fully automatic cell morphology analyzer, the mc-80 film reader, launched by mindray medical in cooperation with tencent, was also unveiled in this exhibition area.

according to relevant persons in charge of mindray medical, the critical care model jointly built by the two parties based on data such as physiological parameters, medical images, tests, medical records, nursing, and doctor's orders has three intelligent applications for critical care departments: "medical record writing, patient personalized information query, and knowledge retrieval." the critical care model can support the use of natural language to query patients' individualized conditions and write medical records, which not only significantly improves the efficiency of doctors in processing large amounts of continuously changing clinical data, but also greatly reduces the workload of doctors in organizing medical records and medical history records.

in addition to the field of critical care, mindray medical and tencent will also work together to explore the application of big models in clinical departments such as emergency, anesthesia, imaging, and laboratory, bringing innovations to potential application scenarios such as auxiliary diagnosis, report generation and review, clinical case and knowledge retrieval, and teaching quality control.

in addition, at the end of this year, mindray medical will also release the industry's first critical care decision support system based on ai large model technology. its goal is to become an intelligent assistant for critical care medical care, and subsequently self-learn and upgrade and optimize through continuous data accumulation.

a $70 billion blue ocean market

in fact, the new service trade format of ai+medical is booming. according to the globalmarketinsights report, the market size of "ai+medical" is expected to grow at an average annual compound growth rate of more than 29% and reach us$70 billion in 2032.

mindray medical's exploration of digital transformation is also a microcosm of the accelerated development of my country's medical industry under the wave of ai. at the special exhibition of health services at the ciftis, digital elements are everywhere, such as the country's first self-built full-process organoid biological sample intelligent management system, the world's first artificial intelligence-assisted diagnosis and treatment robot used in clinical evaluation of stroke, and so on.

there is also continuous support at the policy level. the national medical products administration has established four key support areas: artificial intelligence, new medical biomaterials, high-end medical imaging, and medical robots, to remove the "blocking points" and "difficulties" in the development of the industry.

according to the list of approved innovative medical devices released by the national medical products administration in july 2024, the national medical products administration has approved a total of 27 innovative medical devices since 2024, involving bronchial navigation operation and control systems, fundus image-assisted diagnosis software for fundus lesions, extracorporeal ventricular assist devices, renal artery radiofrequency ablators and many other high-end medical devices, covering surgical robots, artificial intelligence medical devices, cardiopulmonary support assistance systems and other fields.

various signs indicate that with the dual support of policy and market demand, the digital transformation of medical care has been accelerating.

beijing business daily reporter ding ning

report/feedback